The Medical Advisor

“Cancer is not a genetic disease, it’s a metabolic disease,” Thomas N. Seyfried , a well-known scholar in cancer research and a Professor of Biology at Boston College, told The Epoch Times. “Once people understand that cancer is a metabolic disease, then you will begin to see a very big reduction in death and greatly improved quality of life and survival.” Cancer Has Remained High for Decades According to the statistics of the American Cancer Society, although the incidence of cancer in the United States has been declining slowly since the beginning of the 21st century, if we look at it over an extended period of time, we will find that the incidence of cancer is actually increasing, not decreasing. Research suggests that cancer may not be a genetic disorder. (Health 1+1 / The Epoch Times) ...

Quick Answer:  The most consequential 2026 cancer breakthrough is daraxonrasib , an oral RAS(ON) inhibitor that nearly doubled overall survival in previously treated metastatic pancreatic cancer in the phase 3 RASolute 302 trial presented at ASCO 2026. Other major advances include the OPTIMA trial , showing many high-risk breast cancer patients can safely skip chemotherapy after genomic testing; the bispecific antibody ivonescimab , which outperformed standard immunotherapy in squamous lung cancer; continued expansion of CAR-T and cell therapies into solid tumors; and growing, evidence-tiered interest in repurposed drugs and metabolic approaches as complementary strategies. AACR 2026 and ASCO 2026 both emphasized that progress is driven by combining precision diagnostics, immunotherapy, and targeted agents — not a single cure. Despite  trillions spent on cancer research  ( The Lancet Oncology ), cancer still  kills around 10 million people a year  ( WHO )...